All neurotransmitters require an efficient mechanism to terminate their action. Water-soluble neurotransmitters diffuse unassisted in the cytosol to their respective catabolic enzyme for breakdown, after being transported into cells. The endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), are the major signaling molecules for the cannabinoid receptors CB1 and CB2. Unlike most other neurotransmitters, the endocannabinoids are neutral hydrophobic molecules. The hypothesis of this proposal is that, owing to their neutral lipid structure and their insolubility in cytosol, the inactivation of AEA and 2-AG occurs by a unique pathway. It is proposed that they bind to fatty acid binding proteins (FABPs) for intracellular trafficking to their inactivating enzymes. Accordingly, these studies will examine endogenous levels of FABPs in different cells. Furthermore, these studies will elucidate the role of FABPs upon the rate of endocannabinoid metabolism by assaying the cellular uptake and hydrolysis of AEA and 2-AG. The proof that FABPs are intracellular transporters of endocannabinoids will be demonstrated by measuring commensurate changes in metabolism after up-regulation of FABPs by transfection, down-regulation of FABPs by RNA interference or inactivation of FABPs by specific inhibitors. Herein we describe, for the first time, proteins that bind endocannabinoids and function as intracellular transporters. To further strengthen our confidence in the hypothesis that FABPs are intracellular transporters of endocannabinoids, experiments will also be conducted to show that two alternative mechanisms (simple diffusion or endocytosis) are less likely. From a health related viewpoint, understanding the mechanism of endocannabinoid inactivation and identifying FABPs as a new drug target drug target may lead to treatment for addiction, mood disorders, pain and inflammation, cognition, and appetite regulation. For example, competitive inhibitors of AEA and 2-AG binding to specific FABPs will decrease the hydrolysis of AEA and 2-AG as well as their cellular uptake, raising their levels at the synapse and producing a cannabinoid tone.

Public Health Relevance

The two endocannabinoid neurotransmitters, anandamide and 2-AG, are required for normal physiological functioning in humans. Understanding how these compounds are inactivated in the body are the focus of this proposal and will lead to new targets for pharmaceutical drugs. Since anandamide and 2-AG signaling molecules are involved in such diverse functions as reinforcement, mood, memory, appetite, pain and movement;drugs that prevent their inactivation may be good for treating drug addiction, depression, compulsive behaviors, neuropathic pain and movement disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21DA026953-01
Application #
7707842
Study Section
Special Emphasis Panel (ZDA1-MXS-M (02))
Program Officer
Hillery, Paul
Project Start
2009-08-01
Project End
2011-07-31
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
1
Fiscal Year
2009
Total Cost
$156,000
Indirect Cost
Name
State University New York Stony Brook
Department
Biochemistry
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Sanson, BenoƮt; Wang, Tao; Sun, Jing et al. (2014) Crystallographic study of FABP5 as an intracellular endocannabinoid transporter. Acta Crystallogr D Biol Crystallogr 70:290-8
Leung, Kwannok; Elmes, Matthew W; Glaser, Sherrye T et al. (2013) Role of FAAH-like anandamide transporter in anandamide inactivation. PLoS One 8:e79355
Kaczocha, Martin; Vivieca, Stephanie; Sun, Jing et al. (2012) Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors. J Biol Chem 287:3415-24
Kaczocha, Martin; Lin, Qingqing; Nelson, Lindsay D et al. (2012) Anandamide externally added to lipid vesicles containing trapped fatty acid amide hydrolase (FAAH) is readily hydrolyzed in a sterol-modulated fashion. ACS Chem Neurosci 3:364-8
Tsuboi, Kazuhito; Okamoto, Yasuo; Ikematsu, Natsuki et al. (2011) Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways. Biochim Biophys Acta 1811:565-77
Ulloa, Nadine M; Deutsch, Dale G (2010) Assessment of a spectrophotometric assay for monoacylglycerol lipase activity. AAPS J 12:197-201